Heart Disease


To evaluate if treatment with a new drug reduces the risk cardiovascular disease in patients with established cardiovascular disease, chronic kidney disease and inflammation.

Trial overview


Cardiovascular Disease

Eligibility criteria

To be considered for the study you must meet the following criteria:

  • Aged 18 years or older
  • Evidence of cardiovascular disease
  • History of chronic kidney disease and inflammation

Study details

Your participation in this study would be for approximately 3 years. 

You will need to attend the clinic for an initial assessment where a small blood sample will be taken. Eligible participants are required to attend a series of in clinic appointments over the life of the study for drug dispensation and a blood test. During these visits you will also be asked about your health and medications.

You will be reimbursed for travel and study related expenses.

Further information

For more information on this clinical trial here.


Joondalup – Shenton House (Cardiology)

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.